|
|
| |
|
June 20, 2007 |
| |
|
Welcome to ACAAI eNews — a bi-weekly
aggregated
news service
from the American College of Allergy, Asthma & Immunology. To be
removed from this distribution list, please see instructions at
bottom. |
| |
 |
Top
Stories |
|
|
|
 |
Distance Learning |
|
|
|
 |
Drugs and Devices |
|
|
|
 |
Association
News |
| |
|
 |
Fellows-in-Training |
| |
|
 |
Periodicals |
|
|
 |
Calendar |
| |
|
 |
Archive |
|
|
|
|
 |
FIT Archive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distance Learning |
ACAAI
Podcast/Vodcast Library
Link
2006 ACAAI Annual Meeting CD-ROM
Plenary Sessions
Literature Review
International Food Allergy Symposium
Link
|
Periodicals |
•
Annals of
Allergy, Asthma and Immunology
Current issue
• AllergyWatch
Current issue
|
Calendar |
|
JUNE
The Pennsylvania Allergy and Asthma Association Annual
Scientific Meeting
June 22-24, Hershey, Pa.
Tel: 888-633-5784
Link
JULY
Intermountain West Allergy Association
Pending ACAAI Joint Sponsorship
July 19-23, Spokane, Wash.
Tel: 509-924-9722
E-mail
2007 International Congress on Respiratory Viruses
The Macrae Group
July 20-22, Colorado Springs, Colo.
Tel: 212-988-7732
E-mail
Link
25th Annual Aspen Allergy Conference
Pending ACAAI Joint Sponsorship
July 24-28, Aspen, Colo.
Conference Coordinator: Jill Hibbeln
Tel: 720-384-5917
E-mail
Link
AUGUST
Tennessee Society of Allergy, Asthma & Immunology
Pending ACAAI Joint Sponsorship
Aug. 18-20, Knoxville, Tenn.
Tel: 865-342-7057
E-mail
SEPTEMBER
The Long Island Allergy & Asthma
Society
Pending ACAAI Joint
Sponsorship
Sept. 9, Manhasset
Tel: 516-365-6077
E-mail
New York Allergy and Asthma
Society
Pending ACAAI Joint Sponsorship
Sept. 19, New York, N.Y.
Tel: 212-288-2278
E-mail
OCTOBER
Meadowbrook Med Ed Research Foundation at NUMC
Pending ACAAI Joint Sponsorship
Oct. 4, East Meadow, N.Y.
Tel: 718-631-9440
E-mail
1st International Congress on Exacerbations of Airway
Disease (ICEAD)
The Macrae Group
Oct. 4-7, San Juan, Puerto Rico
Tel: (+1) 212.988.7732
E-mail
Link
II Immunotherapy Course: The Insights of Effective
Vaccine for Allergy
Mexican College of Pediatric Allergy & Immunology
Recognized by ACAAI
Oct. 12-13, Mexico City
Tel: +52-55-9000-2008
E-mail
Link
Oregon Society of Allergy, Asthma & Immunology
Pending ACAAI Joint Sponsorship
Oct. 13-14, Mt. Vernon, Va.
Tel: 360-708-9555
E-mail
New York Allergy & Asthma Society
Pending ACAAI Joint Sponsorship
Oct. 26, Brooklyn, N.Y.
Tel: 718-377-0011
E-mail
ONGOING
World Allergy Organization Society Meetings
ACAAI CME Website
Contact: Mary Campbell
Tel: 847-427-1200
E-mail
|
Sponsored
By |
 |
|
|
|
|
|
|
|
|
| |
Top
Stories |
| |
|
Study: Asthma not
controlled in 55 percent
with moderate-to-severe disease
A recent study in the Journal of Allergy and
Clinical Immunology found that asthma was not controlled in
55 percent of Americans with moderate-to-severe asthma,
despite most having health insurance and regularly visiting
a general practitioner. Researchers at Wake Forest
University School of Medicine's Center for Human Genomics
examined data from a Web-based survey of 1,812 patients with
an asthma diagnosis for at least one year and receiving
multiple controller medications. Only 26 percent of subjects
with controlled asthma and 35 percent with uncontrolled
asthma had received an asthma action plan.
Infant antibiotic use may increase asthma risk
Antibiotic use during the first year of life may
increase a child’s risk of developing asthma, according to a
longitudinal Canadian study in Chest. Researchers at the
University of Manitoba in Winnipeg looked at health care and
prescription databases in Manitoba, assessing the
association between antibiotic prescription use during the
first year of life and asthma at 7 years in a 1995 birth
cohort of 13,116 children. The risk was highest among
infants who had received more than four courses of
antibiotics for non-respiratory tract infections, as well as
those who received prescriptions for broad-spectrum
antibiotics — especially broad-spectrum cephalosporins.
Children’s snoring may be tied to
allergic disease
Risk factors for snoring are similar to risk factors
for allergic disease, and snoring may even be part of the
allergic spectrum of diseases, according to an Australian
study in Pediatric Pulmonology. Scientists at the Woolcock
Institute for Medical Research in Sydney evaluated a
subgroup of 213 5-year-olds participating in the Childhood
Asthma Prevention Study whose parents reported that they had
rhinitis for at least one week during the previous year. Of
those children, nearly 60 percent snored at least once a
week and 26 percent snored more than three nights a week.
First-born children were 2.5 times more likely to snore than
children with older siblings, and a mother who smoked at
home during a their first year increased snoring risk
2.4-fold. Children with asthma were 2.51 times more likely
to snore, and children with eczema were 2.29 times more
likely to be snorers. Body mass index had no relationship to
snoring.
|
|
|
A
message from ACAAI President Dr. Daniel Ein
The College has sometimes faced criticism from
members because it is involved with, and devotes
considerable resources to, various international
activities and organizations. The leadership is aware
that attendance by officers and Board members at
meetings overseas is viewed by some as a boondoggle and
an unwarranted privilege. I would agree that it is a
privilege but would also argue that it is an important
activity that is important for the College — and allergy
in general.
In my inaugural remarks last November, I said, “We will
continue to participate in international meetings to
teach, but also to learn.” Some in the audience might
have been skeptical that we have much to learn from
colleagues overseas. My experience is that I learn a
great deal every time I interact with allergists in
their home countries. For example, we know that our
European colleagues have considerable experience with
sublingual immunotherapy (SLIT). We also know that this
treatment is attracting wide attention in the United
States. I think it is crucial for us to learn as much as
possible about SLIT in order to help us evaluate it and
to respond to numerous questions from our patients.
Speaking with those who have prescribed it is one of
many sources of information.
I was recently at a meeting of the Hungarian Allergy and
Clinical Immunology Society, where I was graciously
received by its president, Prof. Kristof Nekam, and by
numerous members. There were fruitful discussions about
how allergy is practiced in our two countries and
conversations about the socioeconomic problems of
medical practice in our two countries. (We complain
about the lack of compensation for what we do but in
Hungary, pay is so poor that many Hungarian physicians,
who are extremely well-trained, are leaving to work
elsewhere.) We also discussed possibilities for
collaboration and joint meetings. And Dr. Larry DuBuske
gave, as an introduction to his talk, an impassioned
presentation about the advantages of College membership.
Some 500 international allergists, many of them in
developing countries, have joined as international
affiliate members to have access to the “virtual”
resources of the College, including Annals and AllergyWatch online, Web site information and
ACAAI
eNews.
These kinds of interactions are repeated frequently
throughout the year, all over the world, and are one of
the cornerstones of our mission. I consider our
international involvements an illustration of the old
adage that one has to give in order to receive. And,
believe me, we do receive a great deal from them.
Our international commitments also extend to the World
Allergy Organization but this involves a different set
of issues, which I intend to discuss in a future
message. |
|
|
|
|
********************************************* |
| Due to technical
difficulties, we are repeating the poll on
Maintenance of Certification discussed in the message
from Dr. Mark L. Corbett, Director, ABAI Board of
Directors featured in the
May
23 issue of ACAAI eNews. Please take a
minute to answer the poll or comment: |
|
 |
| If you currently hold a lifetime certificate, do you plan to participate in MOC? |
 |
|
|
|
|
|
|
Drugs
and Devices |
|
|
|
FDA approves once-daily
antihistamine Xyzal
The U.S. Food and Drug Administration recently approved
levocetirizine dihydrochloride (brand name Xyzal) to treat
nasal allergies and chronic hives in people 6 years and
older, according to manufacturers UCB and sanofi-aventis. A
statement by the companies said the drug significantly
reduced symptoms of sneezing, itchy and runny nose, and
itchy eyes during clinical testing involving more than 2,000
people. It also reduced the severity of itching and the
number and size of wheals among people with chronic hives.
Common side effects included fatigue, dry mouth, and nasal
inflammation.
 |
|
|
Association
News |
| |
|
Literature
Review Course in Philly vodcast weekly
View presentations from the popular Literature Review
Course, Everything You Should Have Read Last Year, But
Didn’t, held at the ACAAI Annual Scientific Meeting last
November, as video podcasts (vodcasts) – when you want,
where you want.
Users can retrieve files manually from the College
Web site or subscribe at no cost to an RSS feed
which will automatically send an alert when a new
presentation is posted. Members can view
30-minute vodcasts of key sessions on their computers or
download them as files directly to portable media players.
Each vodcast contains the original audio and presentation
slides and can be viewed from a computer or downloaded to a
portable media player (such as an iPod).
| The
new Literature Review Course vodcasts include: |
| • |
Basic
Immunology and Genetics for the Allergist – Dr.
David A. Khan (June 20–26) |
| • |
Update
in Clinical Immunology – Dr. John M. Routes (June
27–July 3) |
| • |
Occupational and Environmental Allergy – Dr. Mark S.
Dykewicz (July 4–10) |
Previous vodcasts
from the International Food Allergy Symposium and the
“Asthma Control: How Are We Doing?” symposium are archived
for continued viewing.
The ACAAI vodcast program is sponsored by an unrestricted
educational grant from GlaxoSmithKline.
Drs. Alan and David Redding to star on new
TLC Network TV show, ‘Diagnosis X’
Identical
twin fellows-in-training Dr. Alan R. Redding, University of
Tennessee Health Science Center in Memphis, and Dr. David R.
Redding, University of Texas Medical Branch in Galveston,
Texas, will be acting out an actual allergy-immunology case
together on one episode of a new TLC Network television
drama series titled Diagnosis X starting July 25.
Producers recruited the twins at a fellows-in-training event
at the 2007 AAAAI scientific meeting in San Diego. “They
went to the party hoping to find young doctors who would be
willing and able to provide them with a story and play
themselves. The producers walked up to us and asked if we
wanted to be on television,” said Dr. Alan Redding.
Participating doctors in Diagnosis X provide an
interesting case, and the production company writes a script
based on the case. Dr. Alan Redding said the show is unique
and spontaneous, and although they received tips during
filming, they both actually play themselves.
In their episode, Dr. Alan Redding treats a patient with
IPEX Syndrome, based on a case that he is submitting as an
abstract at the ACAAI Annual Meeting. IPEX Syndrome is a
rare, inherited condition characterized by immune
dysfunction, polyendocrinopathy, enteropathy and X-linked
recessive inheritance. IPEX syndrome leads to death without
prompt diagnosis. He, however, has had good outcomes
treating the disease.
Dr. David Redding was written into the script as his twin
and another doctor on the case. “Alan’s case is well-suited
for the show. Even though I was acting a part, we were
residents together and often consulted with each other
regarding our patients. I am glad they were able to include
me in the program. It was a lot of fun,” he said.
Donated items needed for Silent Auction
The Alliance, the College and the Foundation will again host
a silent auction at the ACAAI Annual Meeting in Dallas. The
proceeds will help support clinical research and education
through Young Faculty Awards, Scholars Return Awards and the
projects of the Consortium on Children’s
Asthma Camps.
We need your support for this worthwhile cause by donating
and soliciting quality
items including artwork, trips,
services, gift items, jewelry, tickets to major events or
hand-crafted items. Cash donations are also welcome for
purchasing auctioned items – an excellent way to add value
to your contribution. The auction items will be available
for viewing in the Alliance Hospitality Suite Friday, and
Saturday morning. The auction will be held Saturday night,
Nov. 10, at the Welcome Reception.
For more details or to make a donation, please call
Marcee Claflin at (405) 340-1274 or e-mail
marceeh519@aol.com. |
|
|
Fellows-in-Training |
| |
Board Review Corner
Welcome to the Board Review Corner prepared by Soo Kim-Delio,
M.D., Senior Representative of ACAAI’s fellows-in-training (FITs)
to the Board of Regents. The Board Review Corner is your chance
to test your Board preparedness.
To refer to a previous Board Review Corner, click the “FIT
Archive” link in the left column.
Review Questions: Chapter 3 of Pediatric Allergy:
Principles & Practices, edited by Donald Y.M. Leung, et al.
Review questions were written by Drs. Bret Haymore, Jiun Yoon and Soo Kim-Delio,
Walter Reed Army Medical Center.
 |
|